Skip to main content
Caplight Logo









nPhase, Inc.

nPhase, Inc.

Private
Encinitas, CaliforniaHealthcare & Life Scienceshttps://redcapcloud.com

Last Round

Series B

Jul 17, 2017

Total Funding Raised

$3.6M

Company Overview

nPhase, Inc. is a software company that provides REDCap Cloud, an enterprise-grade clinical research data platform for clinical trial management and real-world evidence integration.

Sector

Healthcare & Life Sciences

Verticals

Clinical Trials, Vertical SaaS, Compliance

Business Model

B2B

Customer Profile

Subscription SaaS, Services & Consulting

AI Layer

Application

Keywords

EDCelectronic data captureclinical trial managementCTMSeClinicalclinical data managementePROeCOAeConsentclinical research softwareregulatory compliance21 CFR Part 11randomizationRTSMmedical codingvertical SaaS

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

nPhase, Inc. Comparables

Compare nPhase, Inc. with similar companies based on industry and business-model similarity.

nPhase, Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Medrio
94%
Viedoc
90%
Clinion
89%

nPhase, Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series BJul 17, 2017
Series AJan 5, 2016

Key People

Founding team and executive leadership

Mark Lama

CFO, EVP of Bus. Dev. and Co-Founder

Founding Team

Scott Climes

Chief Executive Officer

Executive Team

Dave Sunderhaft

COO

Executive Team

nPhase, Inc. Investors

Notable investors and investment history

nPhase, Inc. investors
InvestorRounds
Vanderbilt UniversitySeries A, Series B

Market signals

Structured signals derived from secondary market and firmographic data.

  • Sep 16, 2025

    Launched version 2.0 of clinical trial data platform.

  • Jun 1, 2025

    Monthly visitors increased 31% MoM to 42.5K.

nPhase, Inc. Filings

Explore SEC and related filing metadata, where available.

nPhase, Inc. filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about nPhase, Inc.'s valuation, stock price, and market status.

Is nPhase, Inc. a public or private company?

nPhase, Inc. is a private company.

What is the current stock price of nPhase, Inc.?

nPhase, Inc. is a private company, so its shares have no public market price. Caplight tracks nPhase, Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is nPhase, Inc. worth (valuation)?

Valuation information for nPhase, Inc. is not publicly available.

Can I buy nPhase, Inc. stock?

nPhase, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was nPhase, Inc.'s last funding round?

nPhase, Inc.'s most recent funding round was Series B on July 17, 2017.

Who are the main investors in nPhase, Inc.?

Key investors in nPhase, Inc. include Vanderbilt University.

Will nPhase, Inc. IPO soon?

No public IPO plans have been announced for nPhase, Inc..

How can I track nPhase, Inc. secondary market activity?

Caplight tracks bids, offers, and trades in nPhase, Inc.'s shares on secondary markets.

Firmographic Details

HeadquartersEncinitas, California
Employee Range138
Year Founded2016
Last FundingJul 17, 2017

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?